MoneyWorks4Me

Amrutanjan Health Care informs about board meeting

25 Oct 2019 Evaluate

Pursuant to the Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), Amrutanjan Health Care has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, the 07th November, 2019 at the registered office of the Company to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2019, and declaration of 1st Interim Dividend for the financial year 2019-20. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..